Clinical Trial Update: Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus [Phase 2]

View source ↗

Summary

Phase 2 trial of combination chemotherapy with sargramostim for uterine sarcoma was terminated, and no results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Sarcoma | Phase 2 | Status: TERMINATED